Johnson & Johnson Reports Q4 and Full-Year 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Johnson & Johnson (JNJ) PT Raised to $163 at Goldman Sachs
January 26, 2022 7:36 AM ESTGoldman Sachs analyst Chris Shibutani raised the price target on Johnson & Johnson (NYSE: JNJ) to $163.00 (from $161.00) while maintaining a Neutral rating.
... MoreJohnson & Johnson (JNJ) Tops Q1 EPS by 1c
January 25, 2022 6:28 AM ESTJohnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.13, $0.01 better than the analyst estimate of $2.12. Revenue for the quarter came in at $24.8 billion versus the consensus estimate of $25.29 billion.
GUIDANCE:
Johnson & Johnson sees FY2022 EPS of $10.40-$10.60, versus the consensus of... More
